Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-26-205182
Filing Date
2026-05-05
Accepted
2026-05-05 08:30:37
Documents
57
Period of Report
2026-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q nerv-20260331.htm   iXBRL 10-Q 1463853
2 EX-31.1 nerv-ex31_1.htm EX-31.1 16586
3 EX-31.2 nerv-ex31_2.htm EX-31.2 16116
4 EX-32.1 nerv-ex32_1.htm EX-32.1 14485
  Complete submission text file 0001193125-26-205182.txt   7639768

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT nerv-20260331.xsd EX-101.SCH 1203321
61 EXTRACTED XBRL INSTANCE DOCUMENT nerv-20260331_htm.xml XML 1457736
Mailing Address 1500 DISTRICT AVENUE BURLINGTON MA 01803
Business Address 1500 DISTRICT AVENUE BURLINGTON MA 01803 617-600-7373
Minerva Neurosciences, Inc. (Filer) CIK: 0001598646 (see all company filings)

EIN.: 260784194 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36517 | Film No.: 26940687
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)